World's Best Scientists 2026 revealed!
Ernesto T. A. Marques

Ernesto T. A. Marques

D-Index & Metrics

Immunology

D-Index
50
Citations
8767
World Ranking
4254
National Ranking
1938

Ernesto T. A. Marques publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ernesto T. A. Marques sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 170 publications — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ernesto T. A. Marques D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ernesto T. A. Marques sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 50 D-Index — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Ernesto T. A. Marques is affiliated with the University of Pittsburgh in the United States. Their research primarily lies within the field of Medicine, with a focus on Public Health, Environmental and Occupational Health, Infectious Diseases, Epidemiology, Modeling and Simulation, and Immunology.

The scientist's recent publications cover a range of topics related to viral infections, mosquito-borne diseases, and COVID-19. Notable papers include "Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults" published in 2024 in the New England Journal of Medicine, and "Severe Acute Respiratory Syndrome Coronavirus 2 Viremia Is Associated With Coronavirus Disease 2019 Severity and Predicts Clinical Outcomes" from 2021 in Clinical Infectious Diseases. Other significant works are "Dengue Virus Targets Nrf2 for NS2B3-Mediated Degradation Leading to Enhanced Oxidative Stress and Viral Replication" (2020, Journal of Virology), "Determinants of the current and future distribution of the West Nile virus mosquito vector Culex pipiens in Spain" (2020, Environmental Research), and "A Glimmer of Hope: Recent Updates and Future Challenges in Zika Vaccine Development" (2020, Viruses).

The scientist collaborates frequently with several researchers, including Priscila M. S. Castanha, Marli Tenório Cordeiro, Tereza Magalhães, Wayner Vieira de Souza, and Thomas Jaenisch.

Publications by this researcher commonly appear in prominent venues such as The Lancet Infectious Diseases, Viruses, PLoS Neglected Tropical Diseases, The Journal of Infectious Diseases, and bioRxiv (Cold Spring Harbor Laboratory).

The main topics covered in their work include:

  • Mosquito-borne diseases and control
  • Viral Infections and Vectors
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 epidemiological studies
  • Malaria Research and Control
  • Virology and Viral Diseases
  • Global Maternal and Child Health

This body of research contributes to understanding infectious disease dynamics, vaccine development, and vector control, focusing on diseases transmitted by mosquitoes and viral pathogens affecting global public health.

Best Publications

  • Establishment and cryptic transmission of Zika virus in Brazil and the Americas

    N R Faria;Joshua Quick;I M Claro;J Thézé

  • Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study

    Thalia Velho Barreto de Araújo;Laura Cunha Rodrigues;Ricardo Arraes de Alencar Ximenes;Ricardo Arraes de Alencar Ximenes;Demócrito de Barros Miranda-Filho

  • Association between microcephaly, Zika virus infection, and other risk factors in Brazil: final report of a case-control study

    Thalia Velho Barreto de Araújo;Ricardo Arraes de Alencar Ximenes;Ricardo Arraes de Alencar Ximenes;Demócrito de Barros Miranda-Filho;Wayner Vieira Souza

  • Computed Tomographic Findings in Microcephaly Associated with Zika Virus.

    Adriano N. Hazin;Andrea Poretti;Danielle Di Cavalcanti Souza Cruz;Marli Tenorio

  • Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region

    Isabel Rodriguez-Barraquer;Federico Costa;Federico Costa;Federico Costa;Eduardo J. M. Nascimento;Nivison Nery Júnior;Nivison Nery Júnior

  • Seroprevalence and risk factors for dengue infection in socio-economically distinct areas of Recife, Brazil.

    Cynthia Braga;Carlos Feitosa Luna;Celina MariaTurchi Martelli;Wayner Vieira de Souza

  • Teratogenic effects of the Zika virus and the role of the placenta

    Jennifer J Adibi;Ernesto T A Marques;Ernesto T A Marques;Abigail Cartus;Richard H Beigi

  • From Re-Emergence to Hyperendemicity: The Natural History of the Dengue Epidemic in Brazil

    Isabel Rodriguez-Barraquer;Marli T. Cordeiro;Cynthia Braga;Wayner V. de Souza

  • Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum

    Irene Bosch;Irene Bosch;Helena de Puig;Megan Hiley;Marc Carré-Camps

  • Positive IgM for Zika virus in the cerebrospinal fluid of 30 neonates with microcephaly in Brazil

    Marli Tenorio Cordeiro;Lindomar J Pena;Carlos A Brito;Laura H Gil

  • Dengue Virus-Specific Antibodies Enhance Brazilian Zika Virus Infection.

    Priscila M S Castanha;Priscila M S Castanha;Eduardo J M Nascimento;Cynthia Braga;Marli T Cordeiro

  • Alternative complement pathway deregulation is correlated with dengue severity.

    Eduardo J. M. Nascimento;Ana M. Silva;Marli T. Cordeiro;Carlos A. Brito

  • SARS-CoV-2 Viremia is Associated with COVID-19 Severity and Predicts Clinical Outcomes.

    Jana L Jacobs;William Bain;Asma Naqvi;Brittany Staines

  • Risk of microcephaly after Zika virus infection in Brazil, 2015 to 2016.

    Thomas Jaenisch;Kerstin Daniela Rosenberger;Carlos Brito;Oliver Brady

  • Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement?

    Mariana L. Palma;Mariana L. Palma;Daniel Zamith-Miranda;Flaviano S. Martins;Fernando A. Bozza

  • Conservation and variability of dengue virus proteins: implications for vaccine design.

    Asif M. Khan;Olivo Miotto;Eduardo J. M. Nascimento;K. N. Srinivasan;K. N. Srinivasan

  • Increased immune responses in rhesus macaques by DNA vaccination combined with electroporation

    Margherita Rosati;Antonio Valentin;Rashmi Jalah;Vainav Patel

  • A systematic bioinformatics approach for selection of epitope-based vaccine targets

    Asif M. Khan;Olivo Miotto;A.T. Heiny;Jerome Salmon

  • Rapid and specific detection of Asian- and African-lineage Zika viruses

    Nunya Chotiwan;Connie D. Brewster;Tereza Magalhaes;Tereza Magalhaes;James Weger-Lucarelli

  • Characterization of a Dengue Patient Cohort in Recife, Brazil

    Marli Tenório Cordeiro;Ana Maria Silva;Carlos A. A. Brito;Eduardo J. M. Nascimento

Frequent Co-Authors

Marli Tenório Cordeiro
Marli Tenório Cordeiro Oswaldo Cruz Foundation
Ulisses M. Braga-Neto
Ulisses M. Braga-Neto Texas A&M University
J. Thomas August
J. Thomas August Johns Hopkins University School of Medicine
Patrícia Brasil
Patrícia Brasil Oswaldo Cruz Foundation
Albert I. Ko
Albert I. Ko Yale University
Mitermayer G. Reis
Mitermayer G. Reis Oswaldo Cruz Foundation
Alberto José da Silva Duarte
Alberto José da Silva Duarte Universidade de São Paulo
Vladimir Brusic
Vladimir Brusic University of Nottingham Ningbo China
Xavier de Lamballerie
Xavier de Lamballerie Aix-Marseille University
Olivo Miotto
Olivo Miotto Mahidol University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, pursuing related online degrees can open diverse career opportunities in healthcare and research. Many begin their journey with foundational programs such as accredited LPN programs easy to get into, which offer a practical approach to entering nursing and patient care. These programs provide essential clinical skills and a stepping stone to advanced roles.

For individuals without a nursing background, there are excellent options like online nursing programs for non nurses. These programs help transition non-nurses into nursing professionals, combining flexible study with comprehensive curriculum tailored to their unique needs.

Accelerated nursing pathways are especially popular for those aiming to advance quickly. The easiest ABSN to get into programs provide a streamlined route to earning a Bachelor of Science in Nursing (BSN), crucial for many immunology-related healthcare roles.

To further specialize, aspiring leaders can pursue an advanced practice through a nurse practitioner accelerated program. This prepares students for high-level clinical responsibilities and research positions closely aligned with immunology and patient care advancements.

Best Scientists Citing Ernesto T. A. Marques

Trending Scientists

Recently Published Articles